Scinai Immunotherapeutics (SCNI) EPS (Basic) (QoQ) (2014 - 2025)
Scinai Immunotherapeutics (SCNI) EPS (Basic) (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Scinai Immunotherapeutics | 1.08 Mn | -3.11 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -69.76% |
| Mar 31, 2025 | 81.98% |
| Dec 31, 2024 | -178.78% |
| Sep 30, 2024 | 155.65% |
| Jun 30, 2024 | -391.83% |
| Mar 31, 2024 | 102.44% |
| Dec 31, 2023 | -338,412,233.83% |
| Sep 30, 2023 | -100.00% |
| Jun 30, 2023 | -28.99% |
| Mar 31, 2023 | 106.35% |
| Dec 31, 2022 | -223,429,532.32% |
| Sep 30, 2022 | -100.00% |
| Jun 30, 2022 | 466.60% |
| Mar 31, 2022 | -132.47% |
| Dec 31, 2021 | 108.21% |
| Sep 30, 2021 | 6.66% |
| Jun 30, 2021 | -333.29% |
| Mar 31, 2021 | 93.23% |
| Dec 31, 2020 | -133.31% |
| Sep 30, 2019 | -494.08% |